EPREX epoetin alfa (rch) 40000IU/mL injection syringe - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
EPREX epoetin alfa (rch) 40000IU/mL injection syringe
AUST R: 73487
Active ingredients:
Epoetin alfa

Dosage form:
Injection, solution

Sponsor:
Janssen-Cilag Pty Ltd

Phone:
1800226334

Deletion from market:
30 Sep 2026

Shortage status:
Discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability

Management action:
Patients are advised to consult their health professional to discuss alternative treatment options.